NYSE:MON - Monsanto Stock Price, Price Target & More

$125.00 +0.32 (+0.26 %)

(As of 04/26/2018 08:55 AM ET)

Previous Close$124.68

Today's Range$125.00 - $125.00

52-Week Range$114.19 - $126.80

Volume15,400 shs

Average Volume3.82 million shs

Market Capitalization$54.99 billion

P/E Ratio22.67

Dividend Yield1.73%

Beta0.96

About Monsanto (NYSE:MON)

Monsanto Company, together with its subsidiaries, provides agricultural products for farmers worldwide. It operates in two segments, Seeds and Genomics, and Agricultural Productivity. The Seeds and Genomics segment produces row crop seeds, including corn, soybean, cotton, and canola seeds under the DEKALB, Asgrow, and Deltapine brands; and vegetable seeds, such as tomato, pepper, melon, cucumber, squash, beans, broccoli, onions, lettuce, and others under the Seminis and De Ruiter brands. It also develops biotechnology traits that assist farmers in controlling insects and weeds in corn, soybean, and cotton crops under the SmartStax, YieldGard, YieldGard VT Triple, VT Triple PRO, and VT Double PRO brands; Intacta RR2 PRO brand; Bollgard and Bollgard II brands; Roundup Ready and Roundup Ready 2 Yield brands; and Roundup Ready 2 Xtend and Bollgard II XtendFlex brands. In addition, this segment licenses a range of germplasm and trait technologies to large and small seed companies. The Agricultural Productivity segment manufactures and sells herbicides for nonselective agricultural and residential lawn and garden applications for weed control under the Roundup brand name; and herbicides for selective agricultural applications for weed control under the XtendiMax brand name. The company markets its products through distributors, independent retailers and dealers, agricultural cooperatives, plant raisers, and agents, as well as directly to farmers. It has strategic alliance with Pairwise Plants to advance agriculture research and development by using gene-editing technology. The company was formerly known as Monsanto Ag Company and changed its name to Monsanto Company in March 2000. Monsanto Company was founded in 2000 and is based in St. Louis, Missouri.

Receive MON News and Ratings via Email

Sign-up to receive the latest news and ratings for MON and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Agricultural chemicals

Sub-IndustryFertilizers & Agricultural Chemicals

SectorBasic Materials

SymbolNYSE:MON

CUSIP61166W10

Webwww.monsanto.com

Phone314-694-1000

Debt

Debt-to-Equity Ratio0.85%

Current Ratio1.41%

Quick Ratio0.85%

Price-To-Earnings

Trailing P/E Ratio22.67

Forward P/E Ratio21.93

P/E Growth2.08

Sales & Book Value

Annual Sales$14.64 billion

Price / Sales3.76

Cash Flow$7.2759 per share

Price / Cash17.18

Book Value$17.62 per share

Price / Book7.09

Profitability

EPS (Most Recent Fiscal Year)$5.50

Net Income$2.26 billion

Net Margins17.07%

Return on Equity37.31%

Return on Assets11.49%

Miscellaneous

Employees23,300

Outstanding Shares440,800,000

How to Become a New Pot Stock Millionaire

Monsanto (NYSE:MON) Frequently Asked Questions

What is Monsanto's stock symbol?

Monsanto trades on the New York Stock Exchange (NYSE) under the ticker symbol "MON."

How often does Monsanto pay dividends? What is the dividend yield for Monsanto?

Monsanto declared a quarterly dividend on Wednesday, January 31st. Shareholders of record on Friday, April 6th will be paid a dividend of $0.54 per share on Friday, April 27th. This represents a $2.16 annualized dividend and a dividend yield of 1.73%. The ex-dividend date of this dividend is Thursday, April 5th. View Monsanto's Dividend History.

How were Monsanto's earnings last quarter?

Monsanto (NYSE:MON) announced its earnings results on Thursday, April, 5th. The basic materials company reported $3.22 EPS for the quarter, missing the Zacks' consensus estimate of $3.31 by $0.09. The basic materials company had revenue of $5.02 billion for the quarter, compared to analysts' expectations of $5.34 billion. Monsanto had a net margin of 17.07% and a return on equity of 37.31%. The business's revenue was down 1.1% compared to the same quarter last year. During the same quarter in the previous year, the business posted $3.19 earnings per share. View Monsanto's Earnings History.

When is Monsanto's next earnings date?

Monsanto is scheduled to release their next quarterly earnings announcement on Wednesday, June, 27th 2018. View Earnings Estimates for Monsanto.

What price target have analysts set for MON?

13 equities research analysts have issued 1 year price targets for Monsanto's shares. Their forecasts range from $119.00 to $128.00. On average, they anticipate Monsanto's share price to reach $126.50 in the next year. View Analyst Ratings for Monsanto.

Who are some of Monsanto's key competitors?

Some companies that are related to Monsanto include Nutrien (NTR), The Mosaic (MOS), CF Industries (CF), Israel Chemicals (ICL), Scotts Miracle-Gro (SMG), Nufarm (NUF), Terra Nitrogen (TNH), American Vanguard (AVD), Calyxt (CLXT), CVR Partners (UAN), Marrone Bio Innovations (MBII), Evogene (EVGN), Wynnstay Group (WYN), China Green Agriculture (CGA) and Arcadia Biosciences (RKDA).

Who are Monsanto's key executives?

Monsanto's management team includes the folowing people:

Mr. Hugh Grant, Exec. Chairman & CEO (Age 60)
Mr. Brett D. Begemann, Pres & COO (Age 57)
Mr. Pierre C. Courduroux, Sr. VP & CFO (Age 53)
Dr. Robert T. Fraley Ph.D., Exec. VP & CTO (Age 65)
Mr. David F. Snively, Exec. VP, Sec. & Gen. Counsel (Age 64)

Has Monsanto been receiving favorable news coverage?

Headlines about MON stock have been trending somewhat positive recently, according to Accern Sentiment Analysis. The research firm identifies negative and positive media coverage by monitoring more than twenty million blog and news sources in real time. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Monsanto earned a news sentiment score of 0.09 on Accern's scale. They also gave media headlines about the basic materials company an impact score of 46.55 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock's share price in the immediate future.

How do I buy shares of Monsanto?

Shares of MON can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Monsanto's stock price today?

One share of MON stock can currently be purchased for approximately $124.68.

How big of a company is Monsanto?

Monsanto has a market capitalization of $54.99 billion and generates $14.64 billion in revenue each year. The basic materials company earns $2.26 billion in net income (profit) each year or $5.50 on an earnings per share basis. Monsanto employs 23,300 workers across the globe.

How can I contact Monsanto?

Monsanto's mailing address is 800 NORTH LINDBERGH BLVD, ST LOUIS MO, 63167. The basic materials company can be reached via phone at 314-694-1000 or via email at [email protected]

MarketBeat Community Rating for Monsanto (MON)

Community Ranking:		3.0 out of 5 ( )
Outperform Votes:		772 (Vote Outperform)
Underperform Votes:		512 (Vote Underperform)
Total Votes:		1,284

MarketBeat's community ratings are surveys of what our community members think about Monsanto and other stocks. Vote "Outperform" if you believe MON will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MON will underperform the S&P 500 over the long term. You may vote once every thirty days.

Monsanto (NYSE:MON) Price Target and Consensus Rating

(How are Consensus Ratings Calculated?)

13 Wall Street analysts have issued ratings and price targets for Monsanto in the last 12 months. Their average twelve-month price target is $126.50, suggesting that the stock has a possible upside of 1.20%. The high price target for MON is $128.00 and the low price target for MON is $119.00. There are currently 1 sell rating, 10 hold ratings and 2 buy ratings for the stock, resulting in a consensus rating of "Hold."

	Today	30 Days Ago	90 Days Ago	180 Days Ago
Consensus Rating:	Hold	Hold	Hold	Hold
Consensus Rating Score:	2.08	2.27	2.27	2.25
Ratings Breakdown:	1 Sell Rating(s) 10 Hold Rating(s) 2 Buy Rating(s) 0 Strong Buy Rating(s)	0 Sell Rating(s) 8 Hold Rating(s) 3 Buy Rating(s) 0 Strong Buy Rating(s)	0 Sell Rating(s) 8 Hold Rating(s) 3 Buy Rating(s) 0 Strong Buy Rating(s)	0 Sell Rating(s) 9 Hold Rating(s) 3 Buy Rating(s) 0 Strong Buy Rating(s)
Consensus Price Target:	$126.50	$127.3333	$127.3333	$124.10
Price Target Upside:	1.20% upside	6.36% upside	6.36% upside	3.72% upside

Monsanto (NYSE:MON) Consensus Price Target History

Price Target History for Monsanto (NYSE:MON)

Monsanto (NYSE:MON) Analyst Ratings History

Show:

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price
4/16/2018	Argus	Downgrade	Buy -> Sell		Low
4/10/2018	BMO Capital Markets	Downgrade	Outperform -> Market Perform		Low
4/9/2018	Sanford C. Bernstein	Reiterated Rating	Neutral	$119.00	High
1/17/2018	Wells Fargo	Reiterated Rating	Market Perform	$118.00 -> $128.00	Low
1/16/2018	Deutsche Bank	Reiterated Rating	Buy		Low
11/15/2017	Royal Bank of Canada	Reiterated Rating	Hold	$128.00	N/A
10/5/2017	Barclays	Reiterated Rating	Equal Weight	$120.00 -> $124.00	N/A
10/4/2017	Macquarie	Downgrade	Outperform -> Neutral		Low
9/15/2017	Jefferies Group	Reiterated Rating	Hold	$128.00	Medium
8/18/2017	UBS	Downgrade	Buy -> Neutral	$128.00	Low
8/11/2017	Piper Jaffray	Set Price Target	Buy	$128.00	Low
7/10/2017	Citigroup	Reiterated Rating	Neutral	$125.00 -> $126.00	Low
6/27/2017	Susquehanna Bancshares	Reiterated Rating	Positive -> Neutral	$125.00 -> $128.00	Low
1/6/2017	CLSA	Upgrade	Underperform -> Outperform		N/A
11/18/2016	OTR Global	Upgrade	Negative -> Mixed		N/A
10/6/2016	JPMorgan Chase	Set Price Target	Buy	$128.00	N/A
10/3/2016	Monness Crespi & Hardt	Lower Price Target	Buy	$130.00 -> $128.00	N/A
9/27/2016	Goldman Sachs	Upgrade	Sell -> Neutral	$104.00	N/A
9/15/2016	S&P Equity Research	Reiterated Rating	Positive		N/A
5/27/2016	Atlantic Securities	Downgrade	Overweight -> Neutral	$109.62 -> $105.00	N/A
5/23/2016	Vertical Research	Upgrade	Hold -> Buy		N/A
5/13/2016	Berenberg Bank	Set Price Target	Buy	$110.00	N/A

(Data available from 4/26/2016 forward)

Monsanto (NYSE:MON) Earnings History and Estimates Chart

Earnings by Quarter for Monsanto (NYSE:MON)

Monsanto (NYSE:MON) Earnings Estimates

2018 EPS Consensus Estimate: $6.21

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2018	1	$0.31	$0.31	$0.31
Q2 2018	1	$3.50	$3.50	$3.50
Q3 2018	1	$1.83	$1.83	$1.83
Q4 2018	1	$0.57	$0.57	$0.57

Monsanto (NYSE MON) Earnings History by Quarter

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call
6/26/2018		$2.10					N/A
4/5/2018	Q2 2018	$3.31	$3.22	$5.3394 billion	$5.0190 billion	View	N/A
1/4/2018	Q1 2018	$0.42	$0.41	$2.7655 billion	$2.6580 billion	View	Listen
10/4/2017	Q4 2017	($0.41)	$0.20	$2.5137 billion	$2.6860 billion	View	N/A
6/28/2017	Q3 17	$1.74	$1.93	$4.1833 billion	$4.23 billion	View	N/A
4/5/2017	Q2 2017	$2.79	$3.19	$4.7320 billion	$5.0740 billion	View	Listen
1/5/2017	Q117	$0.01	$0.21		$2.22 billion	View	Listen
10/5/2016	Q416	($0.02)	$0.07	$2.3790 billion	$2.56 billion	View	Listen
6/29/2016	Q316	$2.40	$2.17	$4.4876 billion	$4.19 billion	View	Listen
4/6/2016	Q216	$2.44	$2.42	$4.81 billion	$4.53 billion	View	N/A
1/6/2016	Q116	($0.22)	($0.11)	$2.41 billion	$2.22 billion	View	Listen
10/7/2015	Q415	($0.02)	($0.19)	$2.79 billion	$2.36 billion	View	Listen
6/24/2015	Q315	$2.06	$2.39	$4.6540 billion	$4.5790 billion	View	Listen
4/1/2015	Q215	$2.93	$2.90	$5.58 billion	$5.1970 billion	View	Listen
1/7/2015	Q115	$0.35	$0.47	$2.80 billion	$2.87 billion	View	Listen
10/8/2014	Q414	($0.24)	($0.27)	$2.41 billion	$2.63 billion	View	Listen
6/25/2014	Q314	$1.55	$1.62	$4.41 billion	$4.25 billion	View	Listen
4/2/2014	Q214	$3.08	$3.15	$5.81 billion	$5.83 billion	View	Listen
1/8/2014	Q1	$0.64	$0.67	$3.08 billion	$3.15 billion	View	Listen
10/2/2013	Q413	($0.43)	($0.47)	$2.24 billion	$2.20 billion	View	Listen
6/26/2013	Q3 2013	$1.59	$1.66	$4.41 billion	$4.25 billion	View	Listen
4/3/2013	Q2 2013	$2.58	$2.73	$5.29 billion	$5.47 billion	View	N/A
1/8/2013	Q1 2013	$0.37	$0.62	$2.64 billion	$2.93 billion	View	Listen
10/3/2012	Q412	($0.43)	($0.44)	$2.25 billion	$2.11 billion	View	N/A
6/27/2012		$1.58	$1.63			View	N/A
4/4/2012		$2.11	$2.28			View	N/A
1/5/2012		$0.17	$0.23			View	N/A
10/5/2011		($0.27)	($0.22)			View	N/A
6/29/2011	Q3 2011	$1.11	$1.26			View	N/A
4/6/2011		$1.84	$1.87			View	N/A
1/6/2011		$0.01	$0.02			View	N/A
10/6/2010	Q4 2010	($0.06)	($0.09)			View	N/A
6/30/2010	Q3 2010	$0.80	$0.81			View	N/A
4/7/2010	Q2 2010	$1.66	$1.70			View	N/A
1/6/2010	Q1 2010	$0.01	($0.02)			View	N/A
10/7/2009	Q4 2009	$0.01	$0.02			View	N/A
6/24/2009	Q3 2009	$1.17	$1.25			View	N/A
4/2/2009	Q2 2009	$2.09	$2.15			View	N/A
1/7/2009	Q1 2009	$0.60	$0.98			View	N/A
10/8/2008	Q4 2008	($0.09)	($0.03)			View	N/A
6/25/2008	Q3 2008	$1.35	$1.45			View	N/A
4/2/2008	Q2 2008	$1.75	$1.79			View	N/A
1/3/2008	Q1 2008	$0.35	$0.46			View	N/A

(Earnings results data provided by Zacks Investment Research)

Monsanto (NYSE:MON) Dividend Information

Monsanto pays an annual dividend of $2.16 per share, with a dividend yield of 1.73%. MON's next quarterly dividend payment will be made on Friday, April 27. Monsanto pays out 39.27% of its earnings out as a dividend.

Next Dividend:	4/27/2018
Annual Dividend:	$2.16
Dividend Yield:	1.73%
Dividend Growth:	6.70% (3 Year Average)
Payout Ratio:	39.27% (Trailing 12 Months of Earnings) 37.89% (Based on This Year's Estimates) 34.29% (Based on Next Year's Estimates)
Frequency:	Quarterly Dividend

Dividend Payments by Quarter for Monsanto (NYSE:MON)

Monsanto (NYSE:MON) Dividend History by Quarter

Announced	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
1/31/2018	quarterly	$0.54	1.85%	4/5/2018	4/6/2018	4/27/2018
12/4/2017	quarterly	$0.54	1.83%	1/4/2018	1/5/2018	1/26/2018
8/10/2017	quarterly	$0.54	1.85%	10/5/2017	10/6/2017	10/27/2017
6/6/2017	quarterly	$0.54	1.83%	7/5/2017	7/7/2017	7/28/2017
1/27/2017	quarterly	$0.54	1.99%	4/5/2017	4/7/2017	4/28/2017
12/6/2016	quarterly	$0.54	2.04%	1/4/2017	1/6/2017	1/27/2017
8/12/2016	quarterly	$0.54	2.06%	10/5/2016	10/7/2016	10/28/2016
6/9/2016	quarterly	$0.54	1.98%	7/6/2016	7/8/2016	7/29/2016
1/29/2016	quarterly	$0.54	2.4%	4/6/2016	4/8/2016	4/29/2016
12/7/2015	quarterly	$0.54	2.23%	1/6/2016	1/8/2016	1/29/2016
8/4/2015	quarterly	$0.54	2.1%	10/7/2015	10/9/2015	10/30/2015
6/8/2015	quarterly	$0.49	1.72%	6/30/2015	7/2/2015	7/24/2015
2/2/2015	quarterly	$0.49	1.65%	3/31/2015	4/2/2015	4/24/2015
12/8/2014	quarterly	$0.49	1.63%	1/7/2015	1/9/2015	1/30/2015
8/5/2014	quarterly	$0.49	1.69%	10/8/2014	10/10/2014	10/31/2014
6/6/2014	quarterly	$0.43	1.42%	7/1/2014	7/3/2014	7/25/2014
1/28/2014	quarterly	$0.43	1.61%	4/2/2014	4/4/2014	4/25/2014
12/9/2013	quarterly	$0.43	1.54%	1/8/2014	1/10/2014	1/31/2014
8/6/2013	quarterly	$0.43	1.81%	10/2/2013	10/4/2013	10/25/2013
6/6/2013	quarterly	$0.3750	1.48%	7/2/2013	7/5/2013	7/26/2013
1/31/2013	quarterly	$0.3750	1.47%	4/3/2013	4/5/2013	4/26/2013

(Data available from 1/1/2013 forward)

Monsanto (NYSE MON) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 0.79%
Institutional Ownership Percentage: 76.23%

Insider Trading History for Monsanto (NYSE:MON)

Institutional Ownership by Quarter for Monsanto (NYSE:MON)

Monsanto (NYSE MON) Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
1/9/2018	Steven Mizell	EVP	Sell	8,100	$119.35	$966,735.00	56,743
11/7/2017	Andrew Thomson	Director	Buy	6,500	$0.17	$1,105.00
10/19/2017	Pierre Courduroux	CFO	Sell	4,320	$122.00	$527,040.00	48,388
10/16/2017	Nicole M Ringenberg	VP	Sell	7,890	$122.25	$964,552.50	38,600
10/9/2017	Steven Mizell	EVP	Sell	11,526	$119.70	$1,379,662.20
9/25/2017	Brett D Begemann	COO	Sell	22,640	$120.03	$2,717,479.20	85,439
9/25/2017	Duraiswami Narain	VP	Sell	2,860	$120.00	$343,200.00
9/1/2017	Andrew Thomson	Director	Buy	9,500	$0.22	$2,090.00
8/9/2017	Andrew Thomson	Director	Buy	5,000	$0.20	$1,000.00
7/10/2017	Robert T. Fraley	EVP	Sell	52,410	$117.95	$6,181,759.50
7/3/2017	Steven Mizell	EVP	Sell	11,300	$118.57	$1,339,841.00	55,011
6/13/2017	Janet M Holloway	SVP	Sell	7,423	$118.00	$875,914.00	33,645
6/2/2017	Janet M Holloway	SVP	Sell	3,337	$118.00	$393,766.00	44,405
5/3/2017	Kerry J Preete	EVP	Sell	11,346	$116.86	$1,325,893.56	39,258
4/17/2017	Brett D Begemann	COO	Sell	80,940	$116.13	$9,399,562.20	148,247
4/10/2017	Hugh Grant	CEO	Sell	149,230	$116.15	$17,333,064.50	390,373
4/10/2017	Steven Mizell	EVP	Sell	13,700	$116.11	$1,590,707.00	50,295
1/25/2017	Michael K Stern	CEO	Sell	5,670	$110.00	$623,700.00	20,534
1/10/2017	Steven Mizell	EVP	Sell	2,525	$108.56	$274,114.00	43,711
11/17/2016	Kerry J. Preete	EVP	Sell	2,745	$100.96	$277,135.20	50,056
10/14/2016	Robert T Fraley	EVP	Sell	80,631	$102.04	$8,227,587.24	38,711
10/10/2016	Charles S Mcmillan	Director	Buy	3,500	$103.23	$361,305.00	64,009
10/10/2016	Steven Mizell	EVP	Sell	310	$103.09	$31,957.90
7/14/2016	Brett D Begemann	COO	Sell	27,980	$103.62	$2,899,287.60	102,480
7/13/2016	Michael K Stern	CEO	Sell	12,797	$101.77	$1,302,350.69	21,583
4/19/2016	George Poste	Director	Sell	1,136	$91.93	$104,432.48	34,619
4/14/2016	Steven Mizell	EVP	Sell	9,500	$89.06	$846,070.00	310
4/12/2016	Charles S Mcmillan	Director	Buy	3,500	$87.25	$305,375.00	58,440
4/12/2016	Michael J Frank	VP	Sell	2,000	$87.49	$174,980.00	35,301
4/11/2016	Steven Mizell	EVP	Sell	3,900	$86.87	$338,793.00	9,810
12/11/2015	Andrew Thomson	Director	Buy	12,000	$0.0350	$420.00
11/17/2015	Kerry J. Preete	EVP	Sell	4,667	$95.62	$446,258.54	41,069
10/21/2015	William U Parfet	Director	Sell	17,000	$91.16	$1,549,720.00	268,814
10/15/2015	Andrew Thomson	Director	Buy	65,000	$0.04	$2,600.00
10/13/2015	Steven Mizell	VP	Sell	6,100	$89.40	$545,340.00	9,374
9/11/2015	Andrew Thomson	Director	Buy	287,000	$0.01	$2,870.00
4/15/2015	Kerry J Preete	EVP	Sell	27,580	$119.37	$3,292,224.60
4/8/2015	Tom D Hartley	VP	Sell	4,600	$117.91	$542,386.00
2/13/2015	Michael K Stern	COO	Sell	1,391	$125.00	$173,875.00
1/20/2015	David F Snively	EVP	Sell	29,521	$117.14	$3,458,089.94
1/12/2015	Steven Mizell	VP	Sell	20,500	$118.72	$2,433,760.00
11/17/2014	Nicole M Ringenberg	VP	Sell	12,780	$118.83	$1,518,647.40
10/15/2014	Robert T Fraley	EVP	Sell	10,679	$107.93	$1,152,584.47
10/14/2014	Nicole M Ringenberg	VP	Sell	2,500	$108.01	$270,025.00
10/13/2014	Steven Mizell	VP	Sell	3,480	$106.08	$369,158.40
9/3/2014	Kerry J Preete	EVP	Sell	3,827	$115.50	$442,018.50
7/8/2014	Michael J Frank	VP	Sell	7,500	$124.53	$933,975.00
7/7/2014	Robert T Fraley	EVP	Sell	54,740	$125.32	$6,860,016.80
7/3/2014	David F Snively	EVP	Sell	35,220	$126.25	$4,446,525.00
7/3/2014	William U Parfet	Director	Sell	23,800	$126.52	$3,011,176.00
5/23/2014	Janet M Holloway	SVP	Sell	21,280	$120.00	$2,553,600.00
5/7/2014	Kerry Preete	EVP	Sell	49,850	$115.00	$5,732,750.00	48,653
4/15/2014	Hugh Grant	CEO	Sell	95,000	$110.33	$10,481,350.00	253,715
4/15/2014	Tom Hartley	VP	Sell	7,900	$110.51	$873,029.00	9,961
1/17/2014	Hugh Grant	CEO	Sell	44,179	$112.69	$4,978,531.51	348,715
1/16/2014	Robert Fraley	EVP	Sell	64,850	$112.57	$7,300,164.50	93,376
1/14/2014	Steven Mizell	VP	Sell	24,000	$112.05	$2,689,200.00	35,482
11/11/2013	Nicole Ringenberg	VP	Sell	13,560	$107.04	$1,451,462.40	5,385
10/15/2013	Tom Hartley	VP	Sell	5,860	$105.70	$619,402.00	8,772
10/8/2013	Steven Mizell	VP	Sell	11,370	$104.50	$1,188,165.00	28,796
10/7/2013	Nicole Ringenberg	VP	Sell	3,500	$105.02	$367,570.00	2,041
9/4/2013	Kerry Preete	EVP	Sell	5,276	$99.00	$522,324.00	41,394
7/19/2013	Gerald A Steiner	EVP	Sell	12,293	$104.00	$1,278,472.00
7/9/2013	Tom D Hartley	VP	Sell	6,000	$100.15	$600,900.00
7/8/2013	Janet M Holloway	SVP	Sell	10,700	$98.80	$1,057,160.00
7/3/2013	Hugh Grant	CEO	Sell	40,000	$97.74	$3,909,600.00
7/2/2013	Steven Mizell	VP	Sell	37,000	$97.71	$3,615,270.00
5/13/2013	David F Snively	EVP	Sell	106,366	$107.24	$11,406,689.84
5/1/2013	Pierre Courduroux	CFO	Sell	5,720	$105.47	$603,288.40

(Data available from 1/1/2013 forward)

Monsanto (NYSE MON) News Headlines

Source:

Date	Headline
	Bayer, Monsanto deal on track for US approval by end of May: source www.reuters.com - April 26 at 8:28 AM
	Bayer, Monsanto deal on track for U.S. approval by end of May -source finance.yahoo.com - April 26 at 8:28 AM
	Comparing Terra Nitrogen (TNH) & Monsanto (MON) www.americanbankingnews.com - April 25 at 7:20 PM
	Monsanto Growth Ventures execs leave, join $250 million life sciences fund www.bizjournals.com - April 25 at 5:20 PM
	Monsanto launches product to deactivate dicamba weedkiller seekingalpha.com - April 25 at 8:31 AM
	BRIEF-Monsanto Collaborates with Adjuvants Unlimited to Develop Sprayer System Cleaner www.reuters.com - April 24 at 5:26 PM
	UBS Downgrades Monsanto (MON) to Neutral www.americanbankingnews.com - April 20 at 3:36 PM
	Monsanto (MON) Upgraded to "Buy" by Vetr www.americanbankingnews.com - April 20 at 11:19 AM
	Russia gives green light to Bayer's takeover of Monsanto: Ifax www.reuters.com - April 20 at 8:39 AM
	Bayer gains Russian approval for Monsanto deal www.marketwatch.com - April 20 at 8:39 AM
	[$$] Data Collective Brings on Monsanto Execs for DCVC Bio finance.yahoo.com - April 20 at 8:39 AM
	Why Sherwin-Williams’s 1Q18 Revenue Could Be Set to Rise finance.yahoo.com - April 20 at 8:39 AM
	What Will It Take for Sherwin-Williams to Beat Analyst Estimates? finance.yahoo.com - April 20 at 8:39 AM
	Monsanto (MON) Lifted to "Buy" at Vetr www.americanbankingnews.com - April 19 at 9:23 AM
	Bayer to Divest 3.6% Stake to Singapore Company Temasek finance.yahoo.com - April 19 at 8:29 AM
	Monsanto (MON) Downgraded by Jefferies Group www.americanbankingnews.com - April 18 at 9:10 PM
	Temasek Chips in $3.7 Billion to Help Bayer Fund Monsanto Deal www.bloomberg.com - April 18 at 8:30 AM
	Germany moving ahead with plans to restrict weed-killer glyphosate www.reuters.com - April 17 at 5:44 PM
	Germany to go forward with plans to restrict Monsanto weedkiller seekingalpha.com - April 17 at 5:44 PM
	Is Guggenheim S&P 500 Equal Weight Materials ETF (RTM) a Hot ETF Right Now? finance.yahoo.com - April 17 at 8:48 AM
	Monsanto (MON) Stock Rating Lowered by Argus www.americanbankingnews.com - April 16 at 9:16 AM
	UPDATE: Argus Double Downgrades Monsanto (MON) to Sell Following Acquisition www.streetinsider.com - April 16 at 8:29 AM
	This Morning's Research Reports on Agricultural Chemicals Stocks -- Monsanto, Nutrien, Mosaic, and Scotts Miracle-Gro www.prnewswire.com - April 16 at 8:29 AM
	Royal Bank of Canada Reaffirms Hold Rating for Monsanto (MON) www.americanbankingnews.com - April 14 at 12:18 PM
	The Mosaic (MOS) vs. Monsanto (MON) Financial Survey www.americanbankingnews.com - April 14 at 7:37 AM
	$4.62 Billion in Sales Expected for Monsanto (MON) This Quarter www.americanbankingnews.com - April 14 at 3:53 AM
	Monsanto loses cotton patent legal battle in India www.bizjournals.com - April 13 at 8:38 AM
	Is It The Right Time To Buy Monsanto Company (NYSE:MON)? finance.yahoo.com - April 12 at 5:23 PM
	Analysts Anticipate Monsanto (MON) Will Post Earnings of $2.19 Per Share www.americanbankingnews.com - April 12 at 9:14 AM
	Netskope to Present with Monsanto at CSA Summit www.prnewswire.com - April 11 at 5:16 PM
	Monsanto loses Indian legal battle over GM cotton patents finance.yahoo.com - April 11 at 5:16 PM
	The Justice Department Is Going to Let Bayer Buy Monsanto. Here's Why It Matters fortune.com - April 11 at 8:46 AM
	FDA Restricts Sale of Bayer's Essure Birth Control Device finance.yahoo.com - April 10 at 5:19 PM
	Monsanto Bayer Takeover finance.yahoo.com - April 10 at 8:44 AM
	Bayer reaches deal with U.S. for approval to buy Monsanto - WSJ finance.yahoo.com - April 10 at 8:44 AM
	Bayer shares jump on report of U.S. antitrust deal on Monsanto finance.yahoo.com - April 10 at 8:44 AM
	[$$] U.S. to Allow Bayer’s Monsanto Takeover finance.yahoo.com - April 10 at 8:44 AM
	Bayer's Lucky General Wins Recruits for $66 Billion Monsanto Deal finance.yahoo.com - April 10 at 8:44 AM
	[$$] Bayer and Monsanto rise on report DoJ will approve tie-up finance.yahoo.com - April 10 at 8:44 AM
	Monsanto (MON) Lowered to "Market Perform" at BMO Capital Markets www.americanbankingnews.com - April 10 at 8:37 AM
	Monsanto (MON) Stock Rating Upgraded by ValuEngine www.americanbankingnews.com - April 10 at 12:33 AM
	RNAgri Inks Deal with Monsanto for Use of St. Louis Startup's RNA Production Technology www.businesswire.com - April 9 at 5:10 PM
	Justice Department to Allow Bayer's Acquisition of Monsanto After Company Concessions www.wsj.com - April 9 at 5:10 PM
	Bayer-Monsanto deal reportedly gets Justice Department's OK, clearing the last big regulatory hurdle www.latimes.com - April 9 at 4:13 PM
	Justice Department to allow Bayer's acquisition of Monsanto: Dow Jones www.cnbc.com - April 9 at 3:19 PM
	WSJ: DoJ to allow Bayer’s acquisition of Monsanto seekingalpha.com - April 9 at 2:19 PM
	Monsanto (MON) Lowered to "Sell" at Zacks Investment Research www.americanbankingnews.com - April 9 at 11:02 AM
	Monsanto (MON) PT Set at $119.00 by Sanford C. Bernstein www.americanbankingnews.com - April 9 at 10:28 AM
	Monsanto’s Overall Profitability in Fiscal 2Q18 finance.yahoo.com - April 9 at 8:39 AM
	Head to Head Review: SenesTech (SNES) vs. Monsanto (MON) www.americanbankingnews.com - April 7 at 9:21 PM